EMA Executive Director Guido Rasi Takes Office
The new executive director of the European Medicines Agency begins appointment.
Professor Guido Rasi has begun his five-year appointment as executive director of the European Medicines Agency (EMA). Rasi was nominated for the position on Oct. 1, 2015 and was appointed Oct. 13, 2015. Rasi served previously as executive director of EMA from November 2011–November 2014.
“I am very happy to be back at the helm of the Agency,” Rasi said in a press release. “We are currently undergoing the most significant transformation of the system of medicine development and authorization that I have seen during my 35-year career in public health, either as a doctor, a researcher or a regulator. It is exciting and challenging to be leading the Agency during this time.”
Professor Rasi previously served as EMA’s principal adviser in charge of strategy and was the director-general of the Italian Medicines Agency from 2008 to
2011. He also worked at the Institute for Experimental Medicine of the National Research Council, Italy and was the director of the Institute of Molecular Medicine of the National Research Council in Rome. Professor Rasi holds a degree in medicine and surgery, with specializations in internal medicine, allergology, and clinical immunology from the University of Rome.
Source: EMA
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
AES Clean Technology Launches Next-Generation OSM Utility Solution for Cleanrooms at INTERPHEX 2025
April 2nd 2025Officially launched at INTERPHEX 2025, the Omni ASCENT is a next-generation off-site manufactured vertical utility solution that offers optimized cleanroom flexibility and efficiency.
